Hormone replacement therapy and cardiovascular risk: the cardiovascular physicians' viewpoint

Area of Science:

• Cardiovascular Health
• Endocrinology
• Women's Health

Background:

• Accumulating evidence suggests hormone replacement therapy (HRT) offers protection against cardiovascular disease (CVD) in women.
• The precise extent of this cardiovascular protection remains incompletely understood.
• Existing data indicates no increased risk of hypertension or thromboembolism with HRT.

Purpose of the Study:

• To evaluate the cardiovascular protective effects of hormone replacement therapy (HRT) in women.
• To clarify the benefits and risks associated with HRT, particularly concerning cardiovascular outcomes.
• To address clinical uncertainty regarding the overall balance of HRT's effects.

Main Methods:

• Review of accumulated evidence on hormone replacement therapy (HRT) and cardiovascular disease.
• Analysis of data concerning HRT's impact on hypertension, thromboembolism, plasma lipids, clotting factors, and hemodynamics.
• Assessment of evidence regarding HRT's efficacy in stroke prevention and cancer risk.

Main Results:

• HRT demonstrates protective effects against cardiovascular disease in women.
• Beneficial impacts observed in plasma lipids, clotting factors, and cardiovascular hemodynamics.
• Evidence for stroke prevention is not convincing, and cancer risks remain a concern.

Conclusions:

• Overall, hormone replacement therapy (HRT) appears to be safe and potentially protective for cardiovascular health in women.
• Further awareness of menopause consequences and HRT benefits is needed for informed decision-making.
• Clinicians require clearer guidance on the risk-benefit profile of HRT for women.